Vivimed Labs rose 1.51% to Rs 476 at 11:20 IST on BSE after the company said that the board of directors of the company at its meeting held on 11 January 2016, approved 5 for 1 stock split.
The announcement was made by the company after market hours yesterday, 11 January 2016.Meanwhile, the S&P BSE Sensex was down 158.15 points or 0.63% at 24,668.21.
On BSE, so far 19,910 shares were traded in the counter as against average daily volume of 45,409 shares in the past one quarter. The stock hit a high of Rs 485 in intraday trade, which is also a record high for the stock. The stock hit a low of Rs 473.60 so far during the day. The stock had hit a 52-week low of Rs 175 on 24 June 2015. The stock had outperformed the market over the past one month till 11 January 2016, rising 20.57% compared with 0.88% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 39.14% as against Sensex's 8.33% decline.
The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 10.
On consolidated basis, Vivimed Labs' net profit rose 45.5% to Rs 23.88 crore on 7.5% growth in net sales to Rs 337.03 crore in Q2 September 2015 over Q2 September 2014.
Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.
Powered by Capital Market - Live News
